Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the the efficacy of TA-650 using Clinical activity index (CAI) score and other evaluation indicators in pediatric patients with moderate to severe ulcerative colitis after TA-650 administration of at a dose of 5 mg/kg at weeks 0, 2, and 6, and then every 8 weeks at weeks 14 and 22. The safety and pharmacokinetics are also evaluated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01585155
Study type Interventional
Source Mitsubishi Tanabe Pharma Corporation
Contact
Status Completed
Phase Phase 3
Start date February 2012
Completion date September 2014

See also
  Status Clinical Trial Phase
Withdrawn NCT04348890 - Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis Phase 1/Phase 2
Recruiting NCT05673278 - Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Completed NCT05591976 - Exercise Training in Youth With Inflammatory Bowel Disease N/A
Terminated NCT03827109 - Peer Mentoring to Improve Self-management in Youth With IBD N/A
Terminated NCT02694042 - Mission is Remission®: How Can a Disease Self-management Website Change Care? N/A